Skip to content

zwangerschapsuitkomsten bij vrouwen met een erfelijke stollingsziekte

An observational study on PRegnancy outcome in women with Inherited bleeding DisordErS

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON23871
Enrollment
135
Registered
2018-01-05
Start date
2018-03-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

von Willebrand disease hemophilia carrier post partum hemorrhage (PPH)

Interventions

three patient reported outcome questionaires after delivery

Sponsors

University Medical Center Utrecht
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: -Ongoing pregnancy beyond 10 weeks after the last menstruation -Carrier of hemophilia A or B or Von Willebrand disease type 1, type 2 or type 3 -Age >18 years

Exclusion criteria

Exclusion criteria: -Another concomitant coagulation disorder that needs a deviation of the treatment advises according to the revised national guideline on the management of pregnancy in hemophilia carriers and von Willebrand disease -Use of therapeutic or intermediate dose LMWH before delivery -Inability to give informed consent

Design outcomes

Primary

MeasureTime frame
The incidence of severe PPH, defined as 1000mL or more blood loss within the first 24 hours after delivery

Secondary

MeasureTime frame
The incidence of primary PPH, defined as 500mL or more blood loss within the first 24 hours after delivery The incidence of late PPH, defined as excessive vaginal blood loss between 24 hours and 12 weeks after delivery needing hospital admission Results of the PRO questionnaires

Contacts

Public ContactKarin Van Galen

Heidelberglaan 100

k.p.m.vangalen@umcutrecht.nl088 75 584 50; 003188 7550490

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)